HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Caterina Uberti-Foppa Selected Research
Caterina Uberti-Foppa Research Topics
Disease
9
Infections
02/2021 - 08/2002
7
Liver Cirrhosis (Hepatic Cirrhosis)
01/2017 - 01/2006
6
Fibrosis (Cirrhosis)
01/2019 - 07/2007
6
Coinfection
01/2019 - 11/2003
5
HIV Infections (HIV Infection)
01/2017 - 08/2002
5
Liver Diseases (Liver Disease)
03/2016 - 01/2006
4
Disease Progression
01/2021 - 11/2003
4
Chronic Hepatitis C
01/2019 - 07/2007
3
COVID-19
01/2021 - 01/2020
3
Hepatitis C
03/2016 - 05/2009
2
Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2017
2
Viremia
01/2022 - 06/2003
2
Chronic Hepatitis (Chronic Active Hepatitis)
01/2017 - 06/2003
2
Hepatitis B
01/2017 - 11/2009
2
Acquired Immunodeficiency Syndrome (AIDS)
01/2013 - 11/2008
2
Papillomavirus Infections
05/2006 - 02/2005
1
Inflammation (Inflammations)
12/2020
1
Chronic Disease (Chronic Diseases)
12/2020
1
Cytokine Release Syndrome
12/2020
1
Pneumonia (Pneumonitis)
01/2020
1
Chronic Hepatitis B
10/2019
1
Hematologic Diseases (Blood Diseases)
01/2019
1
Chronic Renal Insufficiency
01/2019
1
Anorexia
12/2014
1
Nausea
12/2014
1
Liver Failure
11/2009
1
Tuberculosis (Tuberculoses)
11/2008
1
Kaposi Sarcoma (Kaposi's Sarcoma)
11/2008
1
Neoplasms (Cancer)
01/2008
1
Cerebrospinal Fluid Leak
01/2008
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2006
1
Necrosis
01/2006
1
Visceral Leishmaniasis (Kala Azar)
11/2003
1
Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
08/2002
1
Opportunistic Infections (Opportunistic Infection)
08/2002
1
Cryptococcosis
08/2002
1
Toxoplasmosis
08/2002
1
Cerebral Toxoplasmosis
08/2002
Drug/Important Bio-Agent (IBA)
7
Biomarkers (Surrogate Marker)
IBA
01/2021 - 02/2005
5
Antiviral Agents (Antivirals)
IBA
07/2017 - 11/2009
5
Ribavirin (Virazole)
FDA Link
Generic
07/2017 - 10/2014
4
RNA (Ribonucleic Acid)
IBA
01/2022 - 08/2009
4
Antibodies
IBA
01/2020 - 06/2006
3
Interferons
IBA
07/2017 - 10/2014
3
Pharmaceutical Preparations
IBA
10/2014 - 07/2007
2
Anti-Bacterial Agents (Antibiotics)
IBA
02/2021 - 01/2008
2
Cytokines
IBA
12/2020 - 01/2006
2
Simeprevir
IBA
07/2017 - 01/2017
2
Sofosbuvir
IBA
07/2017 - 01/2017
2
Alanine Transaminase (SGPT)
IBA
10/2016 - 01/2006
2
Protease Inhibitors (Protease Inhibitor)
IBA
12/2014 - 10/2014
2
telaprevir
IBA
12/2014 - 10/2014
1
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2022
1
Immunoglobulin A (IgA)
IBA
01/2021
1
Phytochemicals
IBA
12/2020
1
Plant Extracts
IBA
12/2020
1
Polyphenols
IBA
12/2020
1
Antioxidants
IBA
12/2020
1
Proteins (Proteins, Gene)
FDA Link
01/2020
1
Immunoglobulins (Immunoglobulin)
IBA
01/2020
1
Viral RNA
IBA
01/2020
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
10/2019
1
Calcitonin Gene-Related Peptide
IBA
01/2019
1
glecaprevir and pibrentasvir
IBA
01/2019
1
elbasvir
IBA
07/2017
1
daclatasvir
IBA
07/2017
1
grazoprevir
IBA
07/2017
1
Amino Acids
FDA Link
07/2017
1
Cannabinoid Receptors (Cannabinoid Receptor)
IBA
01/2017
1
dolutegravir
IBA
01/2017
1
Rilpivirine (TMC-278)
IBA
01/2017
1
Antigens
IBA
01/2017
1
Hepatitis B Core Antigens
IBA
01/2017
1
Codon (Codons)
IBA
01/2017
1
Vaccines
IBA
01/2017
1
N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
IBA
10/2014
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
08/2013
1
Alanine (L-Alanine)
FDA Link
05/2010
1
Transaminases (Aminotransferases)
IBA
05/2010
1
C-Type Lectins (C-Type Lectin)
IBA
07/2009
1
HCV NS3-4A Protease Inhibitors
IBA
05/2009
1
Reverse Transcriptase Inhibitors
IBA
11/2008
1
Nucleosides
IBA
11/2008
1
Cytochrome P-450 CYP2D6 (CYP2D6)
IBA
07/2007
1
Interferon-gamma (Interferon, gamma)
IBA
01/2006
1
Messenger RNA (mRNA)
IBA
01/2006
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2006
1
Interleukin-10 (Interleukin 10)
IBA
01/2006
1
DNA (Deoxyribonucleic Acid)
IBA
11/2003
Therapy/Procedure
10
Therapeutics
12/2014 - 08/2002
5
Highly Active Antiretroviral Therapy (HAART)
01/2019 - 06/2006
2
Neurosurgical Procedures
02/2021 - 01/2008
2
Duration of Therapy
01/2019 - 07/2017
1
Cell Transplantation
01/2019
1
Art Therapy
08/2013
1
Liver Transplantation
11/2009
1
Craniotomy
01/2008
1
Aftercare (After-Treatment)
11/2003